Coronavirus : the pataquès of the vaccine AstraZeneca - The Point

This should be a great day for the communication of the laboratory AstraZeneca, After Pfizer/BioNTech and Moderna, the laboratory, born from the merger in 1999

Coronavirus : the pataquès of the vaccine AstraZeneca - The Point

This should be a great day for the communication of the laboratory AstraZeneca, After Pfizer/BioNTech and Moderna, the laboratory, born from the merger in 1999 of Swedish Astra and English Zeneca, was the third to announce positive results for its vaccine against the Covid-19, developed with the university of Oxford. Crash ! The ad triumph has finally turned a tangle of scientific.

It should be recognized that the reading of the press release is the initial of Monday November 23 was enough to leave you breathless : the product of AstraZeneca was presented with an average efficiency of about 70 %, but...

Article reserved to subscribers

Already a subscriber ?

sign in

Not a subscriber yet ?

Subscribe

Consult our folder : Covid : the time of the second wave

writing will advise you

Vaccine anti-Sars-CoV-2 : where are the real researchers, The strategies asian to widen the gap
Updated Date: 01 December 2020, 10:34

You need to login to comment.

Please register or login.

RELATED NEWS